Generic and innovative drugs market in CIS countries 2013
Upcoming SlideShare
Loading in...5
×
 

Generic and innovative drugs market in CIS countries 2013

on

  • 610 views

This publication is a compilation of all vital data and analysis concerning the markets for generic and innovative medicines in the CIS region: Russia, Ukraine and Kazakhstan. ...

This publication is a compilation of all vital data and analysis concerning the markets for generic and innovative medicines in the CIS region: Russia, Ukraine and Kazakhstan.

Source: http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013

Statistics

Views

Total Views
610
Views on SlideShare
610
Embed Views
0

Actions

Likes
0
Downloads
6
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Generic and innovative drugs market in CIS countries 2013 Generic and innovative drugs market in CIS countries 2013 Presentation Transcript

    • Development forecasts for 2013-2015Generic and innovative drugs marketin CIS countries 2013Russia, Ukraine and Kazakhstan
    • 2+48 12 618 90 30moreinfo@pmrcorporate.comWhich generic/innovative drugs post the highest sales in this region?How large are these market segments in Russia? Ukraine? Kazakhstan?Which recent regulatory adjustments have altered market conditions?Which countries will experience the quickest rates of growth in the generic/innovativedrug sector between 2013-2015?How do consumers and physicians view generic/innovative drugs in CIS countries?How are the prices of both reimbursed and non-reimbursed generic/innovative drugsregulated in CIS countries?Which companies manufacture the greatest quantities of generic and innovative drugswithin the CIS region?Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and KazakhstanDevelopment forecasts for 2013 -2015Click to buyLanguage:Date of publication:Delivery:Price from:EnglishQ2pdf2000€Find out…http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013
    • +48 12 618 90 30moreinfo@pmrcorporate.com3Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and KazakhstanDevelopment forecasts for 2013-2015http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013Click to buyInformational highlightsRegulations in each country that govern pricing and reimbursementPrice mark ups for applicable medicinesReimbursement structures in each of the CIS countriesAnalysis of changing drug reimbursement listsImpact of reimbursement policy changes on these marketsPeriods of data exclusivity and patent expirationsInnovative and generic medicines generating the highest sales
    • 4+48 12 618 90 30moreinfo@pmrcorporate.comIn-depth market developmentforecasts forthe period 2013-2015 – foreach segment in each country.Forward looking analysis oftrends and events and theirroles in market growthin the years to come.Comparative analysis of vitaldata and current marketconditions in Russia, Ukraineand Kazakhstan based onindustry intelligence obtainedfrom a wide range of sourcesand assembled into oneresource.Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and KazakhstanDevelopment forecasts for 2013 -2015Click to buyComparative analysis Market forecasts Profiles of the most prolificcompanieshttp://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013Major advantagesThe report also featuresinformative profiles of theleading manufacturers ofgeneric and innovativemedicines in CIS countries.
    • 5+48 12 618 90 30moreinfo@pmrcorporate.comAssembling a diverse product portfolioSetup of operations in these market segmentsKeeping current with changing drug listsComparing the regulatory frameworks of CIS countriesAssessing the possibilities for growth in these segmentsCompiling forecasts for market conditions.Companies engaged in the production anddistribution of generic/innovative drugsBusinesses building a strategy for entry into thismarketFinancial service providersPharma-related industryResearch, academic and governmental entities.Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and KazakhstanDevelopment forecasts for 2013 -2015Click to buyWhen to use it? Who uses it?http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013
    • 6+48 12 618 90 30moreinfo@pmrcorporate.comRussia’s Pharma 2020programme and its regulationson foreign generic/innovativedrug producers aimed atstrengthening the domesticpharmaceutical industry.Progress of the Ukrainianreimbursement structure,initiated in 2012.Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and KazakhstanDevelopment forecasts for 2013 -2015Click to buyUkraine Russia Kazakhstanhttp://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013Learn more aboutspecific market issuesProgress on the integration ofGood Manufacturing Practicein Kazakhstan.
    • 7Contact us to learn more about this report Request a customised research or advisory assistance+48 12 618 90 30moreinfo@pmrcorporate.com+48 12 618 90 08request@pmrcorporate.comGeneric and innovative drugs market in CIS countries 2013 - Russia, Ukraine and KazakhstanDevelopment forecasts for 2013 -2015http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013Click here to buy this report
    • 8+48 12 618 90 30moreinfo@pmrcorporate.comWhy do business professionals trust us?As a London-based company,with operations abroad, welooked for the best-in-classMarket Intelligence supplier.PMR brought us quality reportsthat improved our CEE marketknowledge and understanding.We consider PMR a competentand professional company. PMRanalysts understand our needsclearly and their services havefully met our expectations.I strongly recommend thecompany as a reliable partner inproviding economic informationand market analysis.We can now recommendPMR as professional andreliable partner in undertakingresearch and market analysis, aswell as source of businesspublications. We intend tocontinue collaboration withPMR in the future.Click to buy http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013
    • 9+48 12 618 90 30moreinfo@pmrcorporate.comPMRs expertiseClients benefitsBusiness consultingMarket researchData analysis & forecastingMarket intelligence reports & servicesIncreasing revenuesOptimising costsEntering new marketsMonitoring marketsClick to buy http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013What is PMR unique business offer?
    • 10tel.: +48 12 618 90 30fax: +48 12 618 90 08e-mail: moreinfo@pmrcorporate.comwww.pmrpublications.comwww.pmrconsulting.comwww.research-pmr.comBehind the scenestailored research and consulting projects annuallyIn-house professionalsoff-the-shelf market reports per yearonline information portals and pdf periodicalsCentral and Eastern Europe countries analysedPMR is established1995200100703025